| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.
|
Nature
|
2001
|
33.12
|
|
2
|
Appendectomy and protection against ulcerative colitis.
|
N Engl J Med
|
2001
|
3.06
|
|
3
|
Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients.
|
Gut
|
1996
|
2.79
|
|
4
|
Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998.
|
Gut
|
2004
|
2.48
|
|
5
|
Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.
|
Aliment Pharmacol Ther
|
2010
|
2.47
|
|
6
|
Collagenous colitis and fecal stream diversion.
|
Gastroenterology
|
1995
|
2.32
|
|
7
|
Genetic analyses of chromosome 12 loci in Crohn's disease.
|
Gut
|
2000
|
2.30
|
|
8
|
Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn's disease.
|
Aliment Pharmacol Ther
|
2012
|
2.29
|
|
9
|
Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn's disease.
|
Aliment Pharmacol Ther
|
2012
|
2.07
|
|
10
|
Long-term prognosis of clinical symptoms and health-related quality of life in microscopic colitis: a case-control study.
|
Aliment Pharmacol Ther
|
2014
|
2.05
|
|
11
|
Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients.
|
Aliment Pharmacol Ther
|
2013
|
2.05
|
|
12
|
Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence?
|
Gut
|
1999
|
2.01
|
|
13
|
Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis.
|
Gastroenterology
|
1991
|
1.93
|
|
14
|
Systematic review: microscopic colitis.
|
Aliment Pharmacol Ther
|
2006
|
1.81
|
|
15
|
Smoking and inflammatory bowel disease. A case control study.
|
Gut
|
1988
|
1.69
|
|
16
|
Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993.
|
Gut
|
1995
|
1.64
|
|
17
|
Familial occurrence of microscopic colitis: a report on five families.
|
Scand J Gastroenterol
|
2001
|
1.64
|
|
18
|
Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group.
|
J Crohns Colitis
|
2012
|
1.56
|
|
19
|
Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients.
|
Gut
|
2004
|
1.56
|
|
20
|
Prolonged postpartum course of intrahepatic cholestasis of pregnancy.
|
Gastroenterology
|
1993
|
1.40
|
|
21
|
Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease.
|
Gut
|
1992
|
1.18
|
|
22
|
TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort.
|
Am J Gastroenterol
|
2009
|
1.10
|
|
23
|
Collagenous and lymphocytic colitis: a clinical and histopathological review.
|
Can J Gastroenterol
|
2000
|
1.05
|
|
24
|
Autoantibodies and immunoglobulins in collagenous colitis.
|
Gut
|
1996
|
0.99
|
|
25
|
Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease.
|
Gut
|
2005
|
0.97
|
|
26
|
Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients.
|
Gut
|
2006
|
0.94
|
|
27
|
CARD4/NOD1 is not involved in inflammatory bowel disease.
|
Gut
|
2003
|
0.94
|
|
28
|
Yersinia species in collagenous colitis: a serologic study.
|
Scand J Gastroenterol
|
2002
|
0.94
|
|
29
|
IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease.
|
Gut
|
1992
|
0.94
|
|
30
|
Optimum dose of olsalazine for maintaining remission in ulcerative colitis.
|
Gut
|
1994
|
0.92
|
|
31
|
Increased nitric oxide production in collagenous and lymphocytic colitis.
|
Eur J Clin Invest
|
1997
|
0.88
|
|
32
|
Immunohistochemical characterization of lymphocytes in microscopic colitis.
|
J Crohns Colitis
|
2013
|
0.86
|
|
33
|
Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis.
|
Scand J Gastroenterol
|
2001
|
0.85
|
|
34
|
Faecal stream diversion in patients with collagenous colitis.
|
Gut
|
1996
|
0.84
|
|
35
|
Intestinal permeability to polyethylene glycols in monozygotic twins with Crohn's disease.
|
Scand J Gastroenterol
|
1995
|
0.83
|
|
36
|
P-ANCA in monozygotic twins with inflammatory bowel disease.
|
Gut
|
1995
|
0.82
|
|
37
|
Luminal nitric oxide and epithelial expression of inducible and endothelial nitric oxide synthase in collagenous and lymphocytic colitis.
|
Scand J Gastroenterol
|
2003
|
0.82
|
|
38
|
CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
|
Dig Liver Dis
|
2005
|
0.81
|
|
39
|
Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease.
|
Eur J Hum Genet
|
2001
|
0.79
|
|
40
|
Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease and Collagenous Colitis: No Association with Lactoferrin, β-Glucuronidase, Myeloperoxidase, or Proteinase 3.
|
Inflamm Bowel Dis
|
1996
|
0.76
|
|
41
|
Behavioral medicine treatment in chronic constipation with paradoxical anal sphincter contraction.
|
Dis Colon Rectum
|
1991
|
0.76
|
|
42
|
RIP2 polymorphisms in inflammatory bowel diseases.
|
Inflamm Bowel Dis
|
2011
|
0.76
|
|
43
|
Smoking and inflammatory bowel disease.
|
Gastroenterol Hepatol
|
1995
|
0.75
|
|
44
|
Letter: Persisting clinical symptoms in microscopic colitis in remission--authors' reply.
|
Aliment Pharmacol Ther
|
2014
|
0.75
|
|
45
|
Letter: infliximab in severe ulcerative colitis - is it useful for all patients? Authors' reply.
|
Aliment Pharmacol Ther
|
2013
|
0.75
|
|
46
|
Letter: the impact of smoking on clinical outcomes after endoscopic dilatation in Crohn's disease - authors' reply.
|
Aliment Pharmacol Ther
|
2013
|
0.75
|
|
47
|
Serum Procollagen III Propeptide Is Not of Diagnostic Predictive Value in Collagenous Colitis.
|
Inflamm Bowel Dis
|
1995
|
0.75
|
|
48
|
[Intestinal tuberculosis--still a clinical reality].
|
Lakartidningen
|
1992
|
0.75
|
|
49
|
[New knowledge of heredity in inflammatory bowel disease. Specific gene mapping in a EU-project].
|
Lakartidningen
|
1998
|
0.75
|
|
50
|
Are endoscopic and/or histologic findings in gastroduodenal mucosa a predictor of clinical outcome in peptic ulcer disease? A 1-year follow-up study after initial healing with either cimetidine or medium-dose antacid.
|
Scand J Gastroenterol
|
1988
|
0.75
|
|
51
|
Letter: endoscopic balloon dilatation or strictureplasty for stricturing Crohn's disease? Authors' reply.
|
Aliment Pharmacol Ther
|
2012
|
0.75
|
|
52
|
[The first Spur-inspections within medical gastroenterology and hepatology: the shortage of specialists is alarming].
|
Lakartidningen
|
1996
|
0.75
|
|
53
|
[Advancing medical gastroenterology. Continuing education is spreading in the country].
|
Lakartidningen
|
1995
|
0.75
|
|
54
|
Medical therapy of active Crohn's disease.
|
Baillieres Clin Gastroenterol
|
1998
|
0.75
|
|
55
|
Long-term treatment with olsalazine for ulcerative colitis: safety and relapse prevention: a follow-up study.
|
Scand J Gastroenterol Suppl
|
1988
|
0.75
|